Republic of Moldova vs Tanzania, United Republic of: Treatment success rate for patients treated for MDR-TB
Republic of Moldova
74.0%
in 2022
Tanzania, United Republic of
74.0%
in 2022
Republic of Moldova rank
78th
Tanzania, United Republic of rank
78th
Treatment success rate for patients treated for MDR-TB over time
- Republic of Moldova
- Tanzania, United Republic of
How they compare
Republic of Moldova currently reports 74.0% against 74.0% in Tanzania, United Republic of, a difference of 0.0%.
Across all 13 years both countries report, Tanzania, United Republic of has been ahead every year.
Republic of Moldova ranks 78th and Tanzania, United Republic of ranks 78th of 163 countries.
Tanzania, United Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Republic of Moldova | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.5% | 75.2% | 19.7% | Tanzania, United Republic of |
| 2020s | 68.7% | 74.3% | 5.7% | Tanzania, United Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Republic of Moldova or Tanzania, United Republic of?
- Republic of Moldova, at 74.0% against 74.0% in Tanzania, United Republic of as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Republic of Moldova and Tanzania, United Republic of?
- 0.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Tanzania, United Republic of?
- 13 years are reported by both, from 2010 to 2022.
- How do Republic of Moldova and Tanzania, United Republic of rank globally for treatment success rate for patients treated for mdr-tb?
- Republic of Moldova ranks 78th and Tanzania, United Republic of ranks 78th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.